L’hydroxychloroquine dans la prévention du retard de croissance intra-utérin et de la prématurité au cours des grossesses lupiques : revue systématique et méta-analyse

Petri, 1991, Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience, Arthritis Rheum, 34, 1538, 10.1002/art.1780341210 Wong, 2006, Outcome of pregnancy in patients with systemic lupus erythematosus, Taiwan J Obstet Gynecol, 45, 120, 10.1016/S1028-4559(09)60208-4 Ruiz-Irastorza, 1996, Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies, Br J Rheumatol, 35, 133, 10.1093/rheumatology/35.2.133 Buchanan, 1992, A study of 100 high risk lupus pregnancies, Am J Reprod Immunol, 28, 192, 10.1111/j.1600-0897.1992.tb00789.x Lima, 1995, Obstetric outcome in systemic lupus erythematosus, Semin Arthritis Rheum, 25, 184, 10.1016/S0049-0172(95)80030-1 Lima, 1996, A study of sixty pregnancies in patients with the antiphospholipid syndrome, Clin Exp Rheumatol, 14, 131 Aggarwal, 1999, Pregnancy in patients with systemic lupus erythematosus, Aust N Z J Obstet Gynaecol, 39, 28, 10.1111/j.1479-828X.1999.tb03438.x Rodriguez-Caruncho, 2014, Antimalarials in dermatology: mechanism of action, indications, and side effects, Actas Dermosifiliogr, 105, 243, 10.1016/j.ad.2012.10.005 Wallace, 1996, The history of antimalarials, Lupus, 5, 10.1177/0961203396005001021 Page, 1951, Treatment of lupus erythematosus with mepacrine, Lancet, 2, 755, 10.1016/S0140-6736(51)91643-1 Rudnicki, 1975, The efficacy of antimalarials in systemic lupus erythematosus, J Rheumatol, 2, 323 Costedoat-Chalumeau, 2002, Evidence of transplacental passage of hydroxychloroquine in humans, Arthritis Rheum, 46, 1123, 10.1002/art.10150 Costedoat-Chalumeau, 2003, Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group, Arthritis Rheum, 48, 3207, 10.1002/art.11304 Parke, 1988, Antimalarial drugs, systemic lupus erythematosus and pregnancy, J Rheumatol, 15, 607 Ruiz-Irastorza, 2010, Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review, Ann Rheum Dis, 69, 20, 10.1136/ard.2008.101766 Levy, 2001, Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study, Lupus, 10, 401, 10.1191/096120301678646137 Clowse, 2006, Hydroxychloroquine in lupus pregnancy, Arthritis Rheum, 54, 3640, 10.1002/art.22159 Buchanan, 1996, Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases, Ann Rheum Dis, 55, 486, 10.1136/ard.55.7.486 Andreoli, 2017, EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome, Ann Rheum Dis, 76, 476, 10.1136/annrheumdis-2016-209770 Izmirly, 2012, Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/ro-antibody - Associated cardiac manifestations of neonatal lupus, Circulation, 126, 76, 10.1161/CIRCULATIONAHA.111.089268 Leroux, 2015, Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study, Lupus, 24, 1384, 10.1177/0961203315591027 Tan, 1982, The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 25, 1271, 10.1002/art.1780251101 Hochberg, 1997, Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 40, 1725, 10.1002/art.1780400928 1995, Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee, World Health Organ Tech Rep Ser, 854, 1 Haute Autorité de Santé - Guide d’analyse de la littérature et gradation des recommandations. http://www.has-sante.fr/portail/jcms/c_434715/fr/guide-d-analyse-de-la-litterature-et-gradation-des-recommandations. Chen, 2015, Renal biopsy in the management of lupus nephritis during pregnancy, Lupus, 24, 147, 10.1177/0961203314551812 Wilson, 1999, International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop, Arthritis Rheum, 42, 1309, 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F Al Arfaj, 2010, Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia, Lupus, 19, 1665, 10.1177/0961203310378669 Tunks, 2013, Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents, Am J Obstet Gynecol, 208, 10.1016/j.ajog.2012.09.020 Mekinian, 2013, European registry of babies born to mothers with antiphospholipid syndrome, Ann Rheum Dis, 72, 217, 10.1136/annrheumdis-2011-201167 Yang, 2014, Pregnancy-related systemic lupus erythematosus: clinical features, outcome and risk factors of disease flares-a case control study, PloS One, 9 Kwok, 2011, Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus, Lupus, 20, 829, 10.1177/0961203310397967 Buyon, 2015, Predictors of pregnancy outcomes in patients with lupus: a cohort study, Ann Intern Med, 163, 153, 10.7326/M14-2235 Mok, 2004, Clinical predictors of fetal and maternal outcome in Chinese patients with systemic lupus erythematosus, Ann Rheum Dis, 63, 1705, 10.1136/ard.2004.022442 Alarcón, 2011, Multiethnic lupus cohorts: what have they taught us?, Reumatol Clin, 7, 3, 10.1016/j.reuma.2010.11.001 Alarcón, 2006, Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time, Ann Rheum Dis, 65, 1168, 10.1136/ard.2005.046896 Andrade, 2008, Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI) [corrected], Clin Exp Rheumatol, 26, 268 Biggioggero, 2010, The geoepidemiology of the antiphospholipid antibody syndrome, Autoimmun Rev, 9, 10.1016/j.autrev.2009.11.013 Clowse, 2006, Early risk factors for pregnancy loss in lupus, Obstet Gynecol, 107, 293, 10.1097/01.AOG.0000194205.95870.86 Chighizola, 2015, The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature, Lupus, 24, 980, 10.1177/0961203315572714 Alijotas-Reig, 2015, The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 247 consecutive cases, Autoimmun Rev, 14, 387, 10.1016/j.autrev.2014.12.010 Bertoli, 2008, LUMINA study group. Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus, Ann Rheum Dis, 67, 500, 10.1136/ard.2007.076059 Mok, 2016, Hydroxychloroquine serum concentrations and flares of systemic lupus erythematosus: a longitudinal cohort analysis, Arthritis Care Res, 68, 1295, 10.1002/acr.22837 Costedoat-Chalumeau, 2007, Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus, Ann Rheum Dis, 66, 821, 10.1136/ard.2006.067835 Durcan, 2015, Hydroxychloroquine blood levels in systemic lupus erythematosus: clarifying dosing controversies and improving adherence, J Rheumatol, 42, 2092, 10.3899/jrheum.150379 Koh, 2015, Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus, Lupus, 24, 210, 10.1177/0961203314555352 1991, A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group, N Engl J Med, 3, 150